Terms: = Lymphoma AND HOXD13, SPD, 3239, P35453, HOX4I AND Diagnosis
11 results:
1. Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma.
Feng X; Luo X; Yang Y; Fan Y; Ye Q
Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048
[TBL] [Abstract] [Full Text] [Related]
2. Randomized crossover trial of 'Roll-over' technique of abdominal paracentesis versus standard technique in suspected malignant ascites.
Jha DK; Rohilla M; Das CK; Irrinki S; Singh H; Arora A; Saha SC; Gupta P; Mandavdhare HS; Dutta U; Sharma A; Sharma V
Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):295-300. PubMed ID: 36795510
[TBL] [Abstract] [Full Text] [Related]
3. Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.
Ruiz IC; Martelli M; Sehn LH; Vitolo U; Nielsen TG; Sellam G; Bottos A; Klingbiel D; Kostakoglu L
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e804-e814. PubMed ID: 35595618
[TBL] [Abstract] [Full Text] [Related]
4. Serum levels of soluble programmed death-ligand 1 (spd-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
[TBL] [Abstract] [Full Text] [Related]
5. Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis.
Shen H; Ji Y; Zhou D; Zhang Y; Wang W; Sun J; Zhang W
Hematology; 2019 Dec; 24(1):392-398. PubMed ID: 30890046
[TBL] [Abstract] [Full Text] [Related]
6. Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients.
El-Ghammaz AMS; Gadallah HA; Kamal G; Maher MM; Mohamad MA
Clin Exp Med; 2018 Nov; 18(4):505-512. PubMed ID: 29876769
[TBL] [Abstract] [Full Text] [Related]
7. Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia.
Rathe M; Sorensen GL; Wehner PS; Holmskov U; Sangild PT; Schmiegelow K; Müller K; Husby S
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667327
[TBL] [Abstract] [Full Text] [Related]
8. High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
Rossille D; Gressier M; Damotte D; Maucort-Boulch D; Pangault C; Semana G; Le Gouill S; Haioun C; Tarte K; Lamy T; Milpied N; Fest T; ;
Leukemia; 2014 Dec; 28(12):2367-75. PubMed ID: 24732592
[TBL] [Abstract] [Full Text] [Related]
9. [Primary Sjögren's syndrome with lymphocytic interstitial pneumonia, autoimmune hemolytic anemia and an endobronchial amyloid nodule].
Kitada J; Yamad G; Ochi T; Tanaka S; Itoh T; Watanabe A; Satoh M; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2008 Nov; 46(11):960-5. PubMed ID: 19068774
[TBL] [Abstract] [Full Text] [Related]
10. Acquired delta-storage pool deficiency associated with idiopathic myelofibrosis.
Mouly S; Youssefian T; Souni F; Cramer E; Lefrere F; Varet B; Hermine O
Leuk Lymphoma; 2000 May; 37(5-6):623-7. PubMed ID: 11042524
[TBL] [Abstract] [Full Text] [Related]
11. Erythrocyte spermine levels: a prognostic parameter in childhood common acute lymphoblastic leukemia.
Bergeron C; Bansard JY; Le Moine P; Bouet F; Goasguen JE; Moulinoux JP; Le Gall E; Catros-Quemener V
Leukemia; 1997 Jan; 11(1):31-6. PubMed ID: 9001415
[TBL] [Abstract] [Full Text] [Related]
